Table 2.
Age groups | Prevalence of NOD2 3020insC |
---|---|
<41 | 0% (0/10) |
41-50 | 9.7% (3/31) |
51-60 | 17% (8/46)* |
61-70 | 7.3% (4/55) |
>70 | 4.9% (2/41) |
total | 9.1% (17/185) |
* - statistically significant difference as compared to population controls (7.7% (75/974); OR = 2.5, p < 0.05)